Journals / KONURALP TIP DERGİSİ / 2019 / Cilt: 11 - Sayı: 3

Approach to Vitamin B12 Deficiency

Vitamin B12 Yetersizliğine Yaklaşım

Pages
482–488
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Finally, parenteral treatment approaches is accepted as a more accurate method in vitamin B12 deficiency.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Vitamin B12 found in animal foods acts as cofactor in two enzyme systems in the human body.
📊
Key Findings & Data:Vitamin B12 shows the majority of its physiological effects via to its contribution to the homocysteine methionine cycle.
💡
Conclusion & Impact:Finally, parenteral treatment approaches is accepted as a more accurate method in vitamin B12 deficiency.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Vitamin B12 yetmezliği · Metiyonin · Süksinil KoenzimA

Abstract

Vitamin B12 found in animal foods acts as cofactor in two enzyme systems in the human body. Vitamin B12 shows the majority of its physiological effects via to its contribution to the homocysteine methionine cycle. Vitamin B12 deficiency is mostly caused by disorders related to absorption mechanisms and is associated with many diseases primarily neurological and hematological diseases. Due to the large measurement uncertainty, serum vitamin B12 levels should be determined as well as homocysteine levels. Finally, parenteral treatment approaches is accepted as a more accurate method in vitamin B12 deficiency.

Özet

Hayvansal gıdalarda bulunan vitamin B12; insan vücudunda iki enzim sisteminde kofaktör olarak görev alır. Vitamin B12 fizyolojik etkilerinin çoğunluğunu homosistein metiyonin döngüsüne sağladığı katkı yoluyla gösterir. Vitamin B12 yetmezliği çoğunlukla emilim mekanizmaları ile ilişkili bozukluklardan kaynaklanır ve öncelikle nörolojik ve hematolojik hastalıklar olmak üzere pek çok hastalıkla ilişkilendirilir. Ölçüm belirsizliğinin geniş olması nedeniyle serum vitamin B12 seviyesinin tespit edilmesinin yanında homosistein seviyesine de bakılması gereklidir. Son olarak vitamin B12 yetersizliğinde paranteral tedavi yaklaşımı daha doğru bir yöntem olarak kabul görmektedir.

🔖

Cite This Article

SEZGİN, Y. (2019). Approach to Vitamin B12 Deficiency. KONURALP TIP DERGİSİ, Cilt: 11 - Sayı: 3, 482–488. https://ajindex.com/articles/192220

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. . Murray RK, Bender DA, Botham KM, et al. Micronutrients: Vitamins & Minerals, Harper’s Illustrated Biochemistry, 28th Edition. The McGraw-Hill Companies, 2009
  2. . Maralcan M, Ellidokuz E. Vitamin B12 eksikliği. Güncel Gastroenteroloji 2004
  3. 8(3): 199-204. (3). Dharmarajan TS, Adiga GU, Norkus EP. Vitamin B12 deficiency. recognizing subtle symptoms in older adults. Geriatrics March 2003
  4. 58 (3): 30-8. (4). Soysal T. Anemiler, DÜ Cerrahpaşa Tıp Fak. Sürekli Tıp Eğitimi Etkinlikleri, Anemiler Sempozyumu, 2001
  5. . Johnson BS. Antianemic and Hematopoietic Stimulating Drugs. Pharmacology and Therapeutics for Dentistry. 7th Edition. Mosby, 2017:
  6. 358–70. (6). Obeid R, Fedosov SN, Nexo E. Cobalamin coenzyme forms are not likely to be superior to cyano- and hydroxyl-cobalamin in prevention or treatment of cobalamin deficiency. Mol Nutr Food Res 2015
  7. . Dikmen M. Molecular biology of methylenetetrahydrofolate reductase (MTHFR) enzyme and its association with diseases. The Medical Journal of Kocatepe 2004
  8. . Green R. Vitamin B12 deficiency from the perspective of a practicing hematologist. Blood 2017
  9. . Takemoto C, Spremulli LL, Benkowski LA, et al. Unconventional decoding of the AUA codon as methionine by mitochondrial tRNAMet with the anticodon f5CAU as revealed with a mitochondrial in vitro translation system. Nucleic Acids Res 2009
  10. 37(5): 1616-27. (10). Yin J, Li T, Yin Y. Methionine and antioxidant potential. Journal of Antioxidant Activity 2016
  11. 1(2): 17-22. (11). Lentz SR. Does homocysteine promote atherosclerosis? Arterioscler Thromb Vasc Biol.2001
  12. . Mansoor MA, Bergmark C, Svardal AM. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Arterioscler Thromb Vasc Biol 1995
  13. . Stamler JS, Osborne JA, Jaraki O. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest 1993
  14. . Nappo F, De Rosa N, Marfella R. Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins. JAMA 1999
  15. . Lentz SR, Sadler JE. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest 1991
  16. . Rodwell VW, Bender DA, Botham KM, et al. Micronutrients: Vitamins & Minerals, H